Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,220.28 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Better Healthcare Sector ETF: Vanguard's Broad VHT vs. Invesco's Biotechnology-Focused IBBQ ↗
Vanguard's broad sector approach costs half as much and yields twice the dividend, while Invesco's biotech focus delivered stronger 1-year returns but with steeper downside risk. 
Via The Motley Fool
Topics ETFs
News headline image
Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio? ↗
PPH targets drugmakers exclusively with higher returns but steeper costs, while XLV diversifies across medical equipment and providers at a fraction of the fee. 
Via The Motley Fool
Topics ETFs
News headline image
10 Stocks Make Up 60% of This $220 Billion Vanguard ETF. Here's What That Means If the AI Trade Cracks. ↗
How diversified is a 147-stock fund when 10 names hold 60% of the money? 
Via The Motley Fool
Topics Artificial Intelligence ETFs
Eli Lilly (NYSE:LLY): High-Growth Stock with Strong Technical and Fundamental Momentum ↗
Via Chartmill
Eli Lilly (NYSE:LLY) Shows Strong Growth and Breakout Technical Setup ↗
Via Chartmill
News headline image
Eli Lilly, Dell Among Stocks To Watch As Market Leadership Shifts ↗
As AI-related stocks weaken, new leaders emerge. 
Via Investor's Business Daily
Topics Artificial Intelligence
News headline image
Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors? ↗
Novo Nordisk is accusing Eli Lilly of deceptive advertising about GLP-1 drugs. 
Via The Motley Fool
Topics Lawsuit
News headline image
2 Top Growth Stocks to Buy Right Now Without Any Hesitation ↗
There are plenty of reasons to love these companies. 
Via The Motley Fool
News headline image
3 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now ↗
With yields like this, these undervalued tickers aren't apt to remain this cheap forever. 
Via The Motley Fool
Topics Lawsuit
News headline image
Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how branded pharmaceutical... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Which Healthcare ETF Is the Better Buy: Vanguard's VHT or Fidelity's FHLC? ↗
One basis point separates these two healthcare funds. Here is why the bigger decision is whether to own healthcare at all. 
Via The Motley Fool
Topics ETFs
News headline image
iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026? ↗
VanEck's concentrated biotech portfolio surged 30.8% in one year but endured a 39.9% drawdown. iShares offers steadier global healthcare exposure with a 1.5% dividend yield. 
Via The Motley Fool
Topics ETFs
News headline image
There's A Hidden Gem In Eli Lilly's Weight-Loss News — And It Could Slam Compounders ↗
Eli Lilly said Thursday it will delay filing for FDA approval of its next-gen weight-loss drug, retatrutide, until the first quarter. 
Via Investor's Business Daily
News headline image
Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know. ↗
Lilly's purchase of AtaiBeckley is yet another strategic move in its bid to diversify its pipeline. 
Via The Motley Fool
News headline image
Which Is the Better Healthcare ETF: First Trust's High-Conviction FBT or Vanguard's Low-Cost VHT? ↗
FBT surged 51.6% in one year but carries higher risk and costs. VHT offers broader diversification at a fraction of the expense ratio. 
Via The Motley Fool
Topics ETFs
News headline image
Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB? ↗
IBB delivered 44% returns in one year but swung 40% lower at its worst. IXJ grew steadily with half the volatility and a 1.5% dividend yield. 
Via The Motley Fool
Topics ETFs
News headline image
Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ ↗
The VanEck Pharmaceutical ETF (PPH) gives investors a concentrated way to own major drugmakers, while the iShares Global Healthcare ETF (IXJ) spreads exposure across the wider healthcare sector. The... 
Via The Motley Fool
Topics ETFs
News headline image
Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF? ↗
IHE delivered stronger 5-year returns, but VHT's 0.09% expense ratio and 411 holdings offer broader diversification at lower cost. 
Via The Motley Fool
Topics ETFs
News headline image
Is the iShares Healthcare ETF or the Invesco Nasdaq Biotech ETF the Better Bet for Investors in 2026? ↗
One offers global diversification and higher income; the other delivers focused biotech exposure with lower costs and stronger recent gains. 
Via The Motley Fool
Topics ETFs
News headline image
As Healthcare Rallies Is the Vanguard Health Care ETF of the Invesco Pharmaceuticals ETF the Better Fund for 2026? ↗
PJP surged 45% in one year, but VHT's lower costs and higher dividend yield appeal to long-term income investors seeking broad sector exposure. 
Via The Motley Fool
Topics ETFs
News headline image
Want Income for Life? Here Are 3 Stocks to Buy Now and Never Sell. ↗
A strong yield and an impressive track record of dividend growth aren't enough. The underlying business needs to be enduring. 
Via The Motley Fool
Topics Economy
News headline image
Insider Moves Are Sending Mixed Signals Across the Tech Sector ↗
Broadcom sees insider selling after volatile 2026 trading, while Netskope draws heavy insider buying post-earnings drop and Eli Lilly CEO David Ricks purchases Adobe shares. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
PINK vs. IXJ: Which Health Care ETF Is the Better Buy for Investors? ↗
PINK has stronger one-year and three-year returns, while IXJ offers lower costs and a higher dividend yield. 
Via The Motley Fool
Topics ETFs
News headline image
"Deceptive Advertising!" Claims Novo Nordisk in Explosive New GLP-1 Lawsuit Against Eli Lilly. Here's What That Means for Both Stocks. ↗
Novo Nordisk is also demanding that Eli Lilly pull its ads and pay damages. 
Via The Motley Fool
Topics Lawsuit
News headline image
Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT? ↗
One fund owns the giants of global healthcare, while the other bets on 30 smaller biotech companies. 
Via The Motley Fool
Topics ETFs
News headline image
IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy? ↗
IXJ offers a higher dividend yield and lower volatility with global exposure, while RSPH's equal-weight approach posted a stronger 1-year return. 
Via The Motley Fool
Topics ETFs
News headline image
1 Unstoppable Vanguard ETF That Could Turn $500 Per Month Into $1 Million ↗
The Vanguard Growth ETF solely focuses on America's largest growth companies. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
Novo Nordisk Sues Eli Lilly Over Alleged Deceptive Weight Loss Drug Advertising ↗
Novo Nordisk has filed a lawsuit against Eli Lilly, alleging false advertising and deceptive marketing for Zepbound and Mounjaro treatments. 
Via Benzinga
Topics Lawsuit
News headline image
Novo Nordisk's Dividend Story Is Changing -- Here's What Investors Are Missing ↗
Novo Nordisk is offering an attractive 3.5% yield backed by a business where volume is the new focus. 
Via The Motley Fool
News headline image
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:CMPS),(NASDAQ:ATAI),(NYSE:JNJ),(NYSE:LLY) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.